Egetis Therapeutics AB (publ) (EGTX) — Cash Flow Reinvestment Rate
Latest as of March 2019:
0.00x
Egetis Therapeutics AB (publ) (EGTX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2019, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr28.02 Million. See how much free cash does Egetis Therapeutics AB (publ) generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr28.02 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Egetis Therapeutics AB (publ) (None–None)
Year-by-year capital reinvestment analysis for Egetis Therapeutics AB (publ). See Egetis Therapeutics AB (publ) financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow